Providing a comprehensive review of short-and long-term adverse events of both antiresorptive
and anabolic drugs this practical guide updates the clinician on the pathophysiology of
osteoporosis and the principles behind our present and future pharmaceuticals. Leading
practitioners in the field examine all current literature and data regarding the duration and
safety of these therapies with recommendations for clinicians on decision-making and best
practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of
osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture
risk assessment and an examination of treatment failures. Next a number of chapters are
dedicated to the diagnosis presentation and management of atypical femur fractures and
osteonecrosis of the jaw (ONJ) each of which are significant patient concerns when using these
osteoporosis treatments. The introduction and utilization of drug holidays is also discussed
as well as the long-term outlook for management of osteoporotic patients. Written and edited by
experts in the field The Duration and Safety of Osteoporosis Treatment is a balanced resource
for researchers practitioners and policy-makers alike for clinical decision-making and patient
care.
